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immunity by RNA interference (RNAi). Until 
recently, however, it was unclear whether the 
mammalian RNAi pathway has a natural antiviral 
function. In a paper published in October 2013, my 
lab has presented two main lines of evidence to 
support a natural antiviral function of RNAi in 
mammals (Li et al., Science 342:231). First, we 
detected abundant production of canonical viral 
siRNAs during mouse infection by Nodamura virus 
(NoV), a mosquito-transmissible positive-strand 
RNA virus. Second, we found that without viral 
suppression of RNAi by the B2 protein of NoV, 
suckling mice are able to launch an antiviral RNAi 
response sufficiently potent to terminate lethal viral 
infection. Using the suckling mouse model for NoV 
infection, we have recently characterized the 
function and mechanism of antiviral RNAi in 
mammals and the in vivo mechanism of RNAi 
suppression by the viral B2 protein. Results from 
these recent studies and other related studies will be 
presented. 
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Our goal is to understand genomic control of viral 
disease responses focusing on the economically 
most important disease of pigs, porcine reproductive 
and respiratory syndrome (PRRS) (annual losses of 
$664M). The PRRS Host Genetics Consortium 
(PHGC) was established to combine efforts of 
scientists from university, government and 
commercial pig genetics and animal health 
companies to assess the role of genetics in 
determining pig resistance/ susceptibility to PRRS 
virus (PRRSV) infection, pathology and growth 
effects. We utilized a nursery pig PRRSV infection 
model with deep sampling for phenotypic analyses, 
extensive genotyping (60K SNPchip) and a shared 
database http://www.animalgenome.org/lunney/. We 
have completed 15 trials using ~200 
PRRSV-infected pigs each and identified a genomic 
region on SSC4 which has a significant impact on 
variation in viral load and growth response 
following challenge with each of 2 different PRRSV 
isolates. More recent trials involve complex 
challenges (PRRSV and porcine circovirus) 
combined with PRRS vaccines, as well as field trials; 
each comparing pigs with different SSC4 haplotypes. 
To address disease resistance mechanisms we probed 
serum protein expression (antibody and cytokine) 
and the blood transcriptome (using microarrays and 
RNAseq) of PHGC pigs. We have verified proteins 
and genes that are differentially expressed in PRRS 
resistant versus susceptible pigs and are probing this 
data for alternate control and regulatory networks. 
This data will help us identify new resistance 
pathways that may be used for new vaccines and 
biotherapeutics. An alternate gilt PRRSV infection 
model has been established to determine the effects 
of third trimester infection on fetal development and 
viability. Using deep phenotypic analyses and 
genotyping of gilts and fetuses, new predictors of 
PRRS severity in gilts and fetuses are being 
identified. Support: US National Pork Board, USDA 
ARS and NIFA, Genome Canada, Genome Alberta, 
Genome Prairie, pig breeding companies. 
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miRNAs are small non-coding RNAs and emerge as 
key regulators for many developmental processes. 
The mechanism that miRNAs regulate target gene 
expression is either affecting target gene mRNA 
stability or inhibiting mRNA translation upon 
binding mRNA 3'UTR target site. Previous studies 
demonstrated that SNPs identified within either 
miRNAs or their target sequences jeopardized 
